doi: 10.1136/bmj.j4849 10 CooperTCSimmonsEBWebbKBurnsJLKushnerRF
According to FDA prescribing information and clinical trial data, nausea is the most common adverse effect, occurring in 15-44% of patients depending on the specific medication and dose
The goal is not a perfect month
With a device-first approach, Sofwave, UltraClear, BBL HEROic, HALO, and Pure Impact, appearance can be realigned with health
These findings have important clinical implications, as they suggest that GLP-1 analogs could be a viable treatment option for patients with MSH, PSW, or other forms of obesity resulting from MC4R deficiencies
[PMID: 33844974] PubMed record related to this compound for laboratory literature review